3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Recruiting
2
Unknown
1
Active not recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
23
Observational
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Resectable Non-small Cell Lung Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Blood Specimen Collection
121
Surveys and Questionnaires
83
Observation
50
Radiotherapy
40
Drug Therapy
35
Surgical Procedures, Operative
34
Biopsy
31
Specimen Handling
28
Data Collection
28
Watchful Waiting
21
Interviews as Topic
20
Immune Checkpoint Inhibitors
19
Magnetic Resonance Imaging
18
Liquid Biopsy
16
Immunotherapy
15
Magnetic Resonance Spectroscopy
14
Standard of Care
13
pembrolizumab
12
Tomography, X-Ray Computed
12
Ultrasonography
11
trastuzumab deruxtecan
10
lenvatinib
10
Radiosurgery
10
Nivolumab
10
Carboplatin
10
Tissue Banks
9
Restraint, Physical
9
Radiation
9
Neoadjuvant Therapy
9
Endoscopy
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Observational
×
Platinum Compounds
×
Clear all
NCT05363319
2026-05-13
CEMI-LUNG
Regeneron Pharmaceuticals
Recruiting
500 enrolled
NCT06169956
2024-04-18
NENI
Bristol-Myers Squibb
Recruiting
400 enrolled